PCD Pharma Franchise in Telangana — Hyderabad & All 33 Districts | Lxir Medilabs

A PCD pharma franchise in Telangana gives you exclusive rights to promote and distribute Lxir Medilabs products within your assigned district. You build a chemist and doctor network; Lxir handles manufacturing, quality, and dispatch. With district-level monopoly rights and 25–50% product margins, it is one of the most accessible and profitable business models for pharma entrepreneurs in Telangana’s diverse and growing healthcare market.

Lxir Medilabs is the right pharma franchise company in Telangana for four reasons: (1) WHO-GMP, GLP and ISO certified manufacturing — credibility essential in a market shaped by Hyderabad’s pharma manufacturing heritage; (2) 2000+ DCGI-approved formulations across all major therapeutic segments; (3) written district-level monopoly rights; (4) 24-hour dispatch from Baddi. Our 20+ years of experience and 2500+ pan-India franchise associates reflect a proven, trusted track record.

Yes — Telangana is one of South India’s strongest pharma franchise markets. Hyderabad’s Genome Valley and specialist hospital ecosystem generate high-value prescription volume. The Aarogyasri health scheme expands institutional demand across all 33 districts. Tier-2 cities like Warangal, Karimnagar, and Khammam are growing rapidly with private hospital investment. The state’s 35.3 million population creates a broad and consistent prescription base for quality franchise partners.

Yes — Lxir Medilabs guarantees district-level monopoly rights across all 33 Telangana districts, assigned in writing before your first order. No second distributor is placed in your district. Open territories currently include Hyderabad, Rangareddy, Warangal, Karimnagar, Nizamabad, Khammam, Nalgonda, Mahabubnagar, Adilabad, and all remaining Telangana districts.

• Drug License — issued by the Telangana State Drug Authority (mandatory for Schedule H and H1 products)
• GST Registration Certificate — Telangana GSTIN
• PAN Card — individual proprietor or firm
• Aadhaar Card — identity verification
• Cancelled Cheque — bank account details for franchise agreement

Document verification takes 24 hours. Our team can guide you through the Telangana Drug License application if needed.

The minimum investment is ₹25,000–₹35,000 for a starter range of 40–60 SKUs. A standard range of 80–120 products runs ₹40,000–₹60,000. There is no monthly royalty and no hidden charges. The full promotional kit — visual aids, MR bags, doctor pads, samples — is provided free with your first dispatch. ROI is typically achieved within 3–6 months of consistent field activity in Telangana.

Lxir Medilabs manufactures at WHO-GMP and GLP certified facilities in Baddi, Himachal Pradesh. All 2000+ formulations are DCGI-approved. Quality control operates at every stage from raw material sourcing through final packaging. This means products are accepted by Telangana government hospitals, Aarogyasri-empanelled facilities, and the quality-demanding private hospital network in Hyderabad without additional documentation — a practical advantage from Day 1 of your franchise.

In Telangana, the highest-demand segments are: Cardio-Diabetic (very high in Hyderabad’s IT and business professional population), Gastro (strong demand given the dietary culture; PPIs and antacids see consistent prescription volume), General Medicine (widest base across all 33 districts), and Respiratory (consistent in Hyderabad’s urban air quality conditions). Derma is growing rapidly in Hyderabad’s professional demographic, and Pediatric demand is strong across all districts under Aarogyasri’s child health programmes.

Yes — many Lxir Medilabs franchise partners in Telangana cover Hyderabad and adjacent districts under a single franchise agreement. The Greater Hyderabad area spans multiple districts (Hyderabad, Rangareddy, Medchal-Malkajgiri), and a single partner can hold rights across all of them. Territory scope is discussed during the enquiry process and documented in the franchise agreement before your first order is placed.